Atracurium besylate
-
Atracurium besylate
structure -
-
CAS No:
64228-81-5
-
Formula:
C53H72N2O12.2C6H5O3S
-
Chemical Name:
Atracurium besylate
-
Synonyms:
Isoquinolinium,2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,benzenesulfonate (1:2);Isoquinolinium,2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,dibenzenesulfonate;Atracurium besylate;BW 33A;Atracurium dibesylate;Tracrium;Atracurium besilate;Atracurium dibesilate;Wellcome 33A74;Tracur
- Categories:
-
CAS No:
Description
Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. Target: nAChRAtracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is classified as an intermediate-duration non-depolarizing neuromuscular-blocking agent [
Atracurium besylate is the bisbenzenesulfonate salt of atracurium. It has a role as a nicotinic antagonist and a muscle relaxant. It is a quaternary ammonium salt and an organosulfonate salt. It contains an atracurium.|A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.|Atracurium Besylate is a synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to intermediary duration of action and no significant cardiovascular effects. Not dependent on kidney function for elimination, it provides clinical advantages over other non-depolarizing, neuromuscular blocking agents. (NCI04)
Atracurium besylate Basic Attributes
1243.48
1242.500366
264-743-4
760047
DTXSID6022630
C28839
29334900
Safety Information
NONH for all modes of transport
3
24/25
P260, P262, P264, P270, P271, P280, P284, P301+P310, P302+P350, P304+P340, P310, P320, P321, P322, P330, P361, P363, P403+P233, P405, P501
H300
|Danger|H300 (23.61%): Fatal if swallowed [Danger Acute toxicity, oral]|P260, P262, P264, P270, P271, P280, P284, P301+P310, P302+P350, P304+P340, P310, P320, P321, P322, P330, P361, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 72 companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H301 (95.79%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P280, P301+P310, P305+P351+P338, P321, P330, P337+P313, P405, and P501|Aggregated GHS information provided by 95 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
Excessive doses can be expected to produce enhanced pharmacological effects. Overdosage may increase the risk of histamine release and cardiovascular effects, especially hypotension.
Drug Information
For use, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Atracurium is a nondepolarizing skeletal muscle relaxant. Atracurium can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. The duration of neuromuscular block produced by Atracurium is approximately one third to one half the duration of block by d-tubocurarine, metocurine, and pancuronium at initially equipotent doses. As with other nondepolarizing neuromuscular blockers, the time to onset of paralysis decreases and the duration of maximum effect increases with increasing doses of Atracurium. Repeated administration of maintenance doses of Atracurium has no cumulative effect on the duration of neuromuscular block if recovery is allowed to begin prior to repeat dosing. Moreover, the time needed to recover from repeat doses does not change with additional doses. Repeat doses can therefore be administered at relatively regular intervals with predictable results.
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)|Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)
The elimination half-life is approximately 20 minutes.
Atracurium antagonizes the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine.
33 A 74
Atracurium besylate Use and Manufacturing
Non-depolarizing muscle relaxants are 2.5 times more effective than myostatin, but the duration of action is shorter. Used for various surgical operations, especially tracheal intubation and caesarean section. Skeletal muscle relaxant for general anesthesia
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:1243.5
Hydrogen Bond Acceptor Count:18
Rotatable Bond Count:26
Exact Mass:1242.50040612
Monoisotopic Mass:1242.50040612
Topological Polar Surface Area:258
Heavy Atom Count:87
Complexity:1560
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a highly selective, competitive (non-depolarizing) neuromuscular junction blocker. It works mainly by competing for cholinergic receptors and blocking the transmission of acetylcholine. It undergoes Hofmann elimination and naturally degrades at plasma pH and body temperature.
Registered Holders
-
GLAND PHARMA LTD
Active
India
-
TAPI NL B.V.
Active
France
-
Beijing Ansenbo Pharmaceutical Technology Co., Ltd.
Active
China
Recommended Suppliers of Atracurium besylate
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
3 YRS
Business licensedTrader Supplier of Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10,Piracetam,Pregabalin,Ketoprofen,omeprazole,Fullerene C60,Melatonin,Nicotinamide riboside chloride,lactoferrin,Tylosin tartrate,Gentamycin Sulfate,Levamisole HCl,Praziquantel,Ivermectin,GA3,Pepsin,MT2,5 amino 1MQ,selank,semaxInquiryCAS No.: 64228-81-5Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Terbinafine hydrochloride,Carboplatin,Pramipexole dihydrochloride Monohydrate,Cisatracurium Besylate,Rivaroxaban,Lenvatinib,Febuxostat,Pemetrexed,Capecitabine,Oxaliplatin,Cisplatin,Ezetimibe,Mitiglinide Calcium,Lapatinib,Dasatinib,Osimertinib,Olaparib,Palbociclib,Lenalidomide,Bortezomib,Enzalutamide,Pemetrexed disodium heptahydrate,Ropivacaine HCL,Atracurium Besylate,Racecadotril,Apremilast,Vonoprazan Fumarate,Crisaborole,Rimegepant -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 64228-81-5Grade: Industrial GradeContent: 99% -
InquiryCAS No.: 64228-81-5Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Mesoridazine besylate
32672-69-8
-
Cisatracurium besylate
96946-42-8
-
Atracurium besylate
64228-79-1
-
Amlodipine Besylate Formula
111470-99-6
-
2-Bromophenacyl bromide, 90% Formula
49851-55-0
-
1H-Indazol-7-ol Formula
81382-46-9
-
6-Chloro-4-forMyl-nicotinic acid Structure
1031433-06-3
-
3-Hydroxy-2,4,5-trifluorobenzoic acid Structure
116751-24-7
-
What is 2-Methyl-1-heptene
15870-10-7
-
What is 1-(3,5-Dinitrophenyl)ethanone
14401-75-3